Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trial

Eugenio De Corso, Giorgio Walter Canonica, Enrico Heffler, Michał Springer, Tomasz Grzegorzek, Miguel Viana, Zsuzsanna Horváth, Joaquim Mullol, Philippe Gevaert, Justin Michel, Anju T. Peters, Martin Wagenmann, Sherif Zaghloul, Mei Zhang, Mark Corbett, Scott D. Nash, James T. Angello, Amr Radwan, Yamo Deniz, A. Martı́n, Peter W. Hellings